please see here for details
Dr. Erin Brazel
Dr Erin Brazel has a background in molecular and translational microbiology, with a focus on developing new ways of preventing and treating bacterial diseases. Erin completed her PhD at the University of Adelaide in 2020, which investigated repurposing a drug originally developed for Alzheimer’s disease to treat antibiotic resistant pneumococcal pneumonia. In 2020, Erin commenced postdoctoral research focusing on understanding how bacteria infect different host sites and the development of new vaccines. Erin is passionate about translating new innovations from the laboratory to help progress new products towards patients. She helped develop a new pneumococcal vaccine that is currently being investigated in a first-in-human phase 1 clinical trial and is a coinventor on three filed patents related to improved vaccine design and formulation. In 2022, she was awarded a Bridge Industry Fellowship to work with biotechnology company GPN Vaccines on business development. Erin currently leads a program of research focused on novel vaccines targeting a range of pathogens, including bacteria that commonly cause middle ear infections. With support from the Passe & Williams Foundation, Erin will investigate a new combination vaccine approach to help prevent ear infecDetions.
| Other GPRWMF awards received by awardee | Year | |
|---|---|---|
| Junior Fellowship | Developing a new vaccine to prevent bacterial ear infections | 2024 |